CEO & Founder, Director

Asa Abeliovich brings more than 25 years of academic and industry experience in CNS disorders. Asa was the Chief Executive Officer and Founder at Prevail Therapeutics, which was acquired by Eli Lilly in 2021. Prior to that, Asa was Co-Founder of and consulting Chief Innovation Officer at Alector. Asa was a tenured Associate Professor of Pathology, Cell Biology, and Neurology at Columbia University, as well as a member of the Taub Institute for Alzheimer’s Disease and the Aging Brain. He served as an Attending Physician in Neurology at the New York-Presbyterian Hospital and the New York Psychiatric Institute. Asa holds M.D. and Ph.D. degrees from Harvard Medical School and the Massachusetts Institute of Technology (MIT), respectively, and Bachelor’s degrees in life sciences and humanities from MIT.